logo
Taiwan Semiconductor Manufacturing Shares Rise on Strong Outlook. Is It Too Late to Buy the Stock?

Taiwan Semiconductor Manufacturing Shares Rise on Strong Outlook. Is It Too Late to Buy the Stock?

Globe and Mail21-07-2025
Key Points
TSMC posted strong Q2 growth, as demand for artificial intelligence (AI) chips continues to surge.
While tariff uncertainty remains, the company upped its guidance, given the strong demand for AI chips it is seeing.
The company remains one of the best-positioned companies to benefit from the ongoing AI data center build-out.
10 stocks we like better than Taiwan Semiconductor Manufacturing ›
Shares of Taiwan Semiconductor Manufacturing (NYSE: TSM) jumped after the semiconductor contract manufacturer reported strong Q2 results and issued an upbeat outlook. The stock is now up nearly 25% on the year.
The company continues to be an artificial intelligence (AI) infrastructure winner, as it is the world's leading maker of advanced chips for companies like Nvidia and Apple.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »
Let's take a closer look at TSMC's results to see if the stock has more upside, or whether it's too late to buy the stock.
No slowdown in sight
With rivals Intel and Samsung struggling, TSMC has established itself as an invaluable part of the semiconductor value chain due to its scale and technological expertise. The company is the clear leader in manufacturing advanced chips, and more and more of its revenue is coming from its leading-edge nodes. Nodes are a reference to the size of how many transistors can be fit on a chip, and the smaller the node, the greater the processing power and efficiency a chip can have.
In Q2, nodes 7 nanometers (nm) and under accounted for 74% of its revenue, up from 67% a year ago. Its newest 3-nm technology made up 24% of total wafer revenue, jumping from just 15% a year ago.
AI chips were once again the biggest driver of TSMC's revenue growth, with high-performance computing (HPC) accounting for 60% of its revenue in the quarter. HPC revenue climbed 14% sequentially. A year ago, the segment accounted for 52% of the company's revenue.
This helped drive a 44% increase in the company's revenue to $30.1 billion. Its earnings per American depositary receipt (ADR) soared 67% to $2.47 from $1.48 a year ago, while its EPS in local currency climbed 61%.
TSMC once again saw strong year-over-year gross margin expansion; however, it is expecting to see pressure in the future. Gross margin increased 540 basis points year over year to 58.6%, despite the company seeing a currency headwind and dilution from the start-up of its new fab in Arizona. It expects gross margin to fall to 56.5% in Q3 due to currency and the further ramp-up of its new facilities in the U.S. and Japan. It also expects its non-Taiwanese fabs to negatively impact its gross margins by around 2% to 3% a year and then widen to 3% to 4% a year in the later stages of its build-out.
Looking ahead, TSMC forecast Q3 revenue to come in between $31.8 billion and $33 billion, representing about 38% year-over-year growth at the midpoint. It projected its operating margin to range from 45.5% to 47.5%.
TSMC raised its full-year revenue forecast, with it now projecting 30% growth, up from prior guidance of "close to the mid-20% range." The company pointed to accelerating AI demand as a key driver, noting that data center orders have strengthened meaningfully even compared to just three months ago. It also cited growing momentum from sovereign AI projects. That's translating into strong demand for its leading-edge 3-nm and 5-nm chip technologies.
TSMC said it hasn't seen any change in customer behavior due to tariffs, but noted that the risk remains. The company is currently in the middle of investing $165 billion in advanced semiconductor manufacturing in the U.S. The construction of its second fab in Arizona is already complete, and its first fab is already in high-volume production. It has plans to build six fabs, two advanced packaging facilities, and create an R&D center.
Is it too late to buy TSMC stock?
While tariff and trade policy concerns regarding semiconductors remain, the simple fact of the matter is that no other foundry in the world has the scale and technological expertise of TSMC. As such, it will continue to manufacture the majority of advanced chips and is one of the best-positioned companies to continue to benefit from the ongoing AI infrastructure build-out.
While the company is expecting to see some gross margin pressure due to its overseas expansion, it has also seen strong pricing power, so it could have the ability to surprise to the upside in the coming years in this regard. TSMC also should benefit from the recent change of heart by the U.S. to allow Nvidia and Advanced Micro Devices to sell certain chips into China.
Meanwhile, TSMC's stock remains attractively valued, trading at a forward price-to-earnings (P/E) ratio of 26 times based on analysts' 2025 estimates and price/earnings-to-growth ratio (PEG) of around 0.7. Stocks with PEG ratios below 1 are typically considered undervalued.
Taken altogether, I think TSMC continues to be positioned as a long-term winner, and that it's not too late to buy the stock.
Should you invest $1,000 in Taiwan Semiconductor Manufacturing right now?
Before you buy stock in Taiwan Semiconductor Manufacturing, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Taiwan Semiconductor Manufacturing wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!*
Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of July 21, 2025
Geoffrey Seiler has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Advanced Micro Devices, Apple, Intel, Nvidia, and Taiwan Semiconductor Manufacturing. The Motley Fool recommends the following options: short August 2025 $24 calls on Intel. The Motley Fool has a disclosure policy.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Medtronic to announce financial results for its first quarter of fiscal year 2026
Medtronic to announce financial results for its first quarter of fiscal year 2026

Cision Canada

timean hour ago

  • Cision Canada

Medtronic to announce financial results for its first quarter of fiscal year 2026

GALWAY, Ireland, Aug. 5, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, August 19, 2025, for its first quarter of fiscal year 2026, which ended on Friday, July 25, 2025, A news release containing summary financial information will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at A video webcast to discuss results will begin at 7:00 a.m. CDT and can be accessed at Within 24 hours of the video webcast, a replay and transcript of the prepared remarks will be available by clicking on the Events link at Looking ahead, Medtronic plans to report its fiscal year 2026 second, third, and fourth quarter results on Tuesday, November 18, 2025, February 17, 2026, and Wednesday, May 20, 2026, respectively. Confirmation and additional details will be provided closer to the specific event. About Medtronic Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE: MDT), visit and follow Medtronic on LinkedIn. Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. Contacts: Erika Winkels Public Relations +1-763-526-8478 Ryan Weispfenning Investor Relations +1-763-505-4626 SOURCE Medtronic plc

Spectrum Brands Holdings Declares Quarterly Common Stock Dividend of $0.47 Per Share
Spectrum Brands Holdings Declares Quarterly Common Stock Dividend of $0.47 Per Share

Globe and Mail

timean hour ago

  • Globe and Mail

Spectrum Brands Holdings Declares Quarterly Common Stock Dividend of $0.47 Per Share

Spectrum Brands Holdings, Inc. (NYSE: SPB) announced that its Board of Directors today declared a quarterly dividend of $0.47 per share on the Common Stock of the Company. The dividend is payable on September 23, 2025 to shareholders of record as of August 26, 2025. About Spectrum Brands Holdings, Inc. Spectrum Brands is a home-essentials company with a mission to make living better at home. We focus on delivering innovative products and solutions to consumers for use in and around the home through our trusted brands. We are a leading supplier of specialty pet supplies, lawn and garden and home pest control products, personal insect repellents, shaving and grooming products, personal care products, and small household appliances. Helping to meet the needs of consumers worldwide, we offer a broad portfolio of market-leading, well-known and widely trusted brands including Tetra®, DreamBone®, SmartBones®, Nature's Miracle®, 8-in-1®, FURminator®, Healthy-Hide®, Good Boy®, Meowee!®, OmegaOne®, Spectracide®, Cutter®, Repel®, Hot Shot®, Rejuvenate®, Black Flag®, Liquid Fence®, Remington®, George Foreman®, Russell Hobbs®, BLACK + DECKER®, PowerXL®, Emeril Lagasse®, and Copper Chef®. For more information, please visit

Medtronic to announce financial results for its first quarter of fiscal year 2026
Medtronic to announce financial results for its first quarter of fiscal year 2026

Globe and Mail

timean hour ago

  • Globe and Mail

Medtronic to announce financial results for its first quarter of fiscal year 2026

GALWAYIreland , /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, August 19, 2025 , for its first quarter of fiscal year 2026, which ended on Friday, July 25, 2025 , A news release containing summary financial information will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at A video webcast to discuss results will begin at 7:00 a.m. CDT and can be accessed at Within 24 hours of the video webcast, a replay and transcript of the prepared remarks will be available by clicking on the Events link at Looking ahead, Medtronic plans to report its fiscal year 2026 second, third, and fourth quarter results on Tuesday, November 18, 2025 , February 17, 2026 , and Wednesday, May 20, 2026 , respectively. Confirmation and additional details will be provided closer to the specific event. About Medtronic Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway , Ireland , is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE: MDT), visit and follow Medtronic on LinkedIn. Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. Contacts: Public Relations +1-763-526-8478 Ryan Weispfenning Investor Relations +1-763-505-4626 View original content to download multimedia: SOURCE Medtronic plc

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store